Module 1 Comprehensive Drug Study Guide
Gabapentin
- Generic Name: Gabapentin
- Trade Name: Neurontin, Gralise, Horizant
- Classification: Anticonvulsant; Analgesic adjunct; GABA analogue
- Routes of Administration: Oral (PO)
- Action: Gabapentin is structurally related to the inhibitory neurotransmitter gamma-aminobutyric acid (GABA); however, it does not interact with GABA receptors, nor does it inhibit GABA uptake or degradation. Its mechanism of action involves binding with high affinity to the α2δ (alpha-2-delta) subunit of voltage-gated calcium channels in the central nervous system. This binding modulates the release of excitatory neurotransmitters that participate in epileptogenesis and nociception.
- How Supplied:
- Capsules: 100mg, 300mg, 400mg
- Tablets: 600mg, 800mg
- Oral Solution: 250mg/5mL
- Dosage:
- Postherpetic Neuralgia (PHN): Gradual titration starting at 300mg on Day 1, 600mg on Day 2 (300mg twice daily), and 900mg on Day 3 (300mg three times daily). Maintenance dose ranges from 900mg/day to 1800mg/day.
- Epilepsy (Adults/Pediatrics > 12 years): Initial dose of 300mg three times daily (TID). Maintenance ranges from 900mg up to 3600mg/day in divided doses.
- Side Effects: Somnolence, dizziness, ataxia, fatigue, peripheral edema, nystagmus, tremor, and diplopia.
- Special Instructions:
- Do not discontinue treatment abruptly; taper over at least 1 week to minimize the risk of increased seizure frequency.
- Monitor patients for the emergence or worsening of depression, suicidal thoughts, or behavior.
- Dosage adjustment is required in patients with compromised renal function (Creatinine Clearance <60mL/min).
Lyrica
- Generic Name: Pregabalin
- Trade Name: Lyrica
- Classification: Anticonvulsant; Analgesic; Anxiolytic (Schedule V controlled substance)
- Routes of Administration: Oral (PO)
- Action: Pregabalin is a GABA analogue that acts by binding to the α2δ subunit of voltage-gated calcium channels in the CNS. By binding to these channels, it reduces the calcium-dependent release of several neurotransmitters, including glutamate, norepinephrine, and substance P. This effectively dampens hyperexcitable neurons and reduces neuropathic pain signals.
- How Supplied:
- Capsules: 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, 300mg
- Oral Solution: 20mg/mL
- Dosage:
- Diabetic Peripheral Neuropathy: Initial dose of 50mg three times daily (150mg/day); may increase to 300mg/day within 1 week.
- Fibromyalgia: 75mg twice daily; may increase to 150mg twice daily within 1 week (up to 450mg/day).
- Side Effects: Dizziness, somnolence, dry mouth, edema, blurred vision, weight gain, and "thinking abnormal" (primarily difficulty with concentration/attention).
- Special Instructions:
- Discontinuation should be done gradually over a minimum of 1 week.
- Instruct patients to report any unexplained muscle pain, tenderness, or weakness (potential for rhabdomyolysis).
Buspirone
- Generic Name: Buspirone Hydrochloride
- Trade Name: Buspar
- Classification: Antianxiety agent (Anxiolytic); Non-benzodiazepine
- Routes of Administration: Oral (PO)
- Action: The exact mechanism is unknown, but it functions as a high-affinity agonist for serotonin 5-HT1A receptors and a moderate affinity antagonist for dopamine D2 receptors. Unlike benzodiazepines, it lacks anticonvulsant, muscle relaxant, or sedative-hypnotic properties and has no significant affinity for the GABA receptor complex.
- How Supplied:
- Tablets: 5mg, 7.5mg, 10mg, 15mg, 30mg
- Dosage:
- Generalized Anxiety Disorder (GAD): Initial dose is 15mg/day (7.5mg twice daily). Dosage may be increased by 5mg per day every 2 to 3 days to a maximum of 60mg/day.
- Side Effects: Dizziness, nausea, headache, nervousness, lightheadedness, and excitement.
- Special Instructions:
- Therapeutic effects may take 3 to 4 weeks to manifest; patients should be informed that it is not for immediate PRN (as needed) relief of acute anxiety.
- Avoid consumption of large amounts of grapefruit juice, as it can increase serum levels.
Ritalin
- Generic Name: Methylphenidate Hydrochloride
- Trade Name: Ritalin, Concerta, Methylin, Daytrana
- Classification: Central Nervous System (CNS) Stimulant (Schedule II controlled substance)
- Routes of Administration: Oral (PO), Transdermal patch
- Action: It is a mild CNS stimulant that blocks the reuptake of norepinephrine and dopamine into the presynaptic neuron and increases the release of these monoamines into the extraneuronal space. It primarily affects the brain stem arousal system and the cerebral cortex.
- How Supplied:
- Immediate-release Tablets: 5mg, 10mg, 20mg
- Extended-release (SR)Tablets: 20mg
- Dosage:
- ADHD (Pediatric): Initial dose of 5mg twice daily (before breakfast and lunch). Increase by 5 to 10mg weekly up to a maximum of 60mg/day.
- Narcolepsy (Adult): Average dose is 20 to 30mg/day divided into 2 to 3 doses.
- Side Effects: Tachycardia, palpitations, increased blood pressure, insomnia, nervousness, anorexia, and weight loss.
- Special Instructions:
- Monitor growth (height and weight) in pediatric patients during long-term therapy.
- Regular monitoring of blood pressure and heart rate is mandatory.
- Administer the last dose of the day before 6:00PM to prevent insomnia.
Lorazepam
- Generic Name: Lorazepam
- Trade Name: Ativan
- Classification: Benzodiazepine; Anxiolytic; Sedative-hypnotic (Schedule IV controlled substance)
- Routes of Administration: Oral (PO), Intramuscular (IM), Intravenous (IV)
- Action: Lorazepam enhances the effects of the inhibitory neurotransmitter GABA by binding to specific benzodiazepine receptors on the post-synaptic GABA-A receptor complex. This increases the frequency of chloride channel opening, leading to hyperpolarization and reduced neuronal excitability.
- How Supplied:
- Tablets: 0.5mg, 1mg, 2mg
- Injection: 2mg/mL, 4mg/mL
- Dosage:
- Anxiety: 2 to 6mg/day in divided doses (largest dose at bedtime).
- Insomnia due to anxiety: 2 to 4mg at bedtime.
- Status Epilepticus (IV): 4mg administered slowly at a rate of 2mg/min.
- Side Effects: Sedation, dizziness, weakness, unsteadiness, respiratory depression (especially when mixed with alcohol or opioids), and physical/psychological dependence.
- Special Instructions:
- Avoid alcohol use during therapy.
- Abrupt withdrawal after long-term use can cause life-threatening seizures and tremors.
Neupro
- Generic Name: Rotigotine
- Trade Name: Neupro
- Classification: Dopamine Agonist (Non-ergoline)
- Routes of Administration: Transdermal (Patch)
- Action: Rotigotine acts as a non-ergoline dopamine agonist with high affinity for D3, D2, and D1 receptors. Its mechanism for Parkinson’s disease involves the stimulation of dopamine receptors in the caudate-putamen of the brain.
- How Supplied:
- Transdermal patch providing: 1mg/24h, 2mg/24h, 3mg/24h, 4mg/24h, 6mg/24h, and 8mg/24h.
- Dosage:
- Parkinson's Disease (Early Stage): Starting dose of 2mg/24h, titrated up weekly by 2mg to a maximum of 6mg/24h.
- Restless Legs Syndrome (RLS): Starting dose of 1mg/24h, titrated up to a maximum of 3mg/24h.
- Side Effects: Application site reactions (redness/itching), nausea, somnolence, hallucinations, and sleep attacks (sudden onset of sleep).
- Special Instructions:
- Rotate patch application sites daily; do not use the same site twice in 14 days.
- Remove the patch before MRI (contains aluminum in the backing).
Seroquel
- Generic Name: Quetiapine Fumarate
- Trade Name: Seroquel, Seroquel XR
- Classification: Atypical Antipsychotic
- Routes of Administration: Oral (PO)
- Action: Quetiapine acts as an antagonist at multiple neurotransmitter receptors, including serotonin 5-HT1A and 5-HT2, dopamine D1 and D2, histamine H1, and adrenergic α1 and α2 receptors. Its antipsychotic effect is thought to be mediated through a combination of dopamine D2 and serotonin 5-HT2 antagonism.
- How Supplied:
- Tablets: 25mg, 50mg, 100mg, 150mg, 200mg, 300mg, 400mg
- Dosage:
- Schizophrenia: Initial dose of 25mg twice daily; titration up to 300 to 400mg/day by Day 4.
- Bipolar Disorder (Manic episodes): Up to 800mg/day.
- Side Effects: Weight gain, hyperglycemia (metabolic shifts), somnolence, dry mouth, orthostatic hypotension, and increased risk of Tardive Dyskinesia.
- Special Instructions:
- Boxed Warning: Increased mortality in elderly patients with dementia-related psychosis.
- Monitor for signs of Neuroleptic Malignant Syndrome (NMS) and QTc interval prolongation.
Botox
- Generic Name: OnabotulinumtoxinA
- Trade Name: Botox, Botox Cosmetic
- Classification: Neuromuscular Blocking Agent (Neurotoxin)
- Routes of Administration: Intramuscular (IM), Intradermal, or Intradetrusor injection
- Action: Botox acts by binding to receptor sites on motor nerve terminals and entering the nerve terminals. Within the nerve, the toxin inhibits the release of acetylcholine (ACh) by cleaving SNAP-25, a protein integral to the successful docking and release of ACh from vesicles. This results in localized chemical denervation and muscle paralysis.
- How Supplied:
- Vacuum-dried powder in single-use vials: 100units or 200units.
- Dosage:
- Chronic Migraine: Recommended total dose is 155units administered as 0.1mL (equivalent to 5units) injections across 31 specific muscle sites.
- Cervical Dystonia: Dosage individualized based on muscle mass and head/neck position.
- Side Effects: Muscle weakness at the injection site, drooping eyelids (ptosis), neck pain, and flu-like symptoms.
- Special Instructions:
- Boxed Warning: The effects of the toxin may spread from the area of injection to other areas of the body, causing symptoms similar to botulism (respiratory distress, swallowing difficulties).
- The potency units of Botox are not interchangeable with other botulinum toxin products (e.g., Dysport, Xeomin).
Amitriptyline
- Generic Name: Amitriptyline Hydrochloride
- Trade Name: Elavil (Discontinued brand), Vanatrip
- Classification: Tricyclic Antidepressant (TCA)
- Routes of Administration: Oral (PO)
- Action: Amitriptyline inhibits the membrane pump mechanism responsible for the reuptake of norepinephrine and serotonin at the presynaptic nerve terminals. By blocking reuptake, it increases the concentration of these monoamines in the synaptic cleft, which is believed to underpin its antidepressant and analgesic effects. It also possesses significant anticholinergic and sedative properties.
- How Supplied:
- Tablets: 10mg, 25mg, 50mg, 75mg, 100mg, 150mg
- Dosage:
- Depression (Outpatient): Initially 75mg/day in divided doses, or 50 to 100mg at bedtime. May increase to 150mg/day.
- Neuropathic Pain (Off-label): Often started at low doses of 10 to 25mg at bedtime.
- Side Effects: Anticholinergic effects (dry mouth, blurred vision, urinary retention, constipation), weight gain, orthostatic hypotension, and cardiac arrhythmias (QT prolongation).
- Special Instructions:
- Use with caution in patients with a history of seizures or cardiovascular disease.
- Lethal in overdose; strictly monitor patients with suicidal ideation due to cardiac toxicity (wide QRS complex).